Vineet Laboratories
41.19
+0.49(+1.20%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+1.20%
1M-12.71%
6M+31.85%
1Y-23.25%
5Y-10.84%
View Company Insightsright
More news about Vineet Laboratories
12Aug 25
Vineet Laboratories Seeks Shareholder Approval for Capital Increase and Director Appointment
Vineet Laboratories Limited's Board of Directors has approved proposals requiring shareholder approval through a postal ballot. The key proposals include increasing the authorized share capital, raising financial thresholds for loans and investments, and appointing Mr. Premananda Reddy Vennapusa as a Non-Executive Director. The cut-off date for voting is set for August 8, 2025, with the board meeting held on August 12, 2025. The company has informed both BSE and NSE about these developments in compliance with SEBI regulations.
09Aug 25
Vineet Laboratories Promoters Reduce Stakes, Sell Shares Worth Over ₹3 Crore
Two promoters of Vineet Laboratories Limited have sold shares, reducing their stakes in the company. Satyanarayana Raju Bhupathiraju sold 18,728 shares on BSE, reducing his holding to 406,452 shares. Gaddam Venkata Rama sold 9,725 shares on NSE, decreasing her stake to 2.82% of total shareholding. The company has complied with SEBI regulations by promptly informing both BSE and NSE about these transactions.
08Aug 25
Vineet Laboratories Promoters Offload Shares Worth Over ₹1.4 Crore
Three promoters of Vineet Laboratories Limited have sold a total of 1,86,165 shares valued at approximately ₹59.06 lakh. Mrs. Gaddam Venkata Rama sold 1,10,000 shares, reducing her stake from 4.12% to 2.93%. Mr. Alluri Prabhakar Raju sold 49,165 shares, decreasing his holding from 2.58% to 2.05%. Mrs. Alluri Maithili offloaded 27,000 shares, lowering her stake from 1.68% to 1.38%. All transactions were executed on the NSE through on-market sales, in compliance with SEBI regulations.
24Jul 25
Vineet Laboratories Promoter Reduces Stake Through Two Share Sale Transactions
Valluru Vara Prasad Rao, a promoter of Vineet Laboratories Limited, has reduced his shareholding through two separate transactions on the NSE. The first sale of 607 shares reduced his stake from 17.97% to 17.37%. The second sale of 14,000 shares further decreased his holding to 14.15%. In total, the promoter's stake has been reduced by approximately 3.82 percentage points. The company has duly informed the stock exchanges about these transactions in compliance with SEBI regulations.
22Jul 25
Vineet Laboratories Reports Reduced Net Loss in Q1 FY2026
Vineet Laboratories Limited (VLL) reported a net loss of ₹86.61 lakh for Q1 FY2026, improving from a ₹213.07 lakh loss in Q1 FY2025. However, revenue declined sharply to ₹744.18 lakh from ₹2,386.16 lakh year-over-year. Total expenses were ₹836.14 lakh. The company's EPS improved to -₹0.94 from -₹2.31. As of June 30, 2025, total assets stood at ₹8,854.38 lakh, with total equity at ₹1,382.00 lakh. The Board approved these results on July 22, 2025, and auditors NSVR & Associates LLP issued an unqualified review report.
Vineet Laboratories
41.19
+0.49
(+1.20%)
1 Year Returns:-23.25%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)